Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.30 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | HTR3A | P46098 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2383882 | 1.00 | CHRM2 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL6682011 | 0.89 | NPSR1 (0.39) | CHRM1NPSR1PAOXALDH1A1 | |
| SCHEMBL736604 | 0.89 | NPSR1 (0.39) | CHRM1NPSR1PAOXALDH1A1 | |
| SCHEMBL15846634 | 0.87 | NPSR1 (0.38) | NPSR1PAOXALDH1A1CYP2C19 | |
| SCHEMBL6260809 | 0.86 | CA12 (0.33) | — | |
| SCHEMBL9619012 | 0.84 | GRIK1 (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL6911774 | 0.83 | CA12 (0.37) | CHRM2LMNACYP2C19CYP2D6 | |
| Hydrochloric Acid SCHEMBL17289188 | 0.82 | GRIK1 (0.33) | — | |
| SCHEMBL37961 | 0.82 | ALDH1A1 (0.36) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL37962 | 0.82 | ALDH1A1 (0.36) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025097070-A1 | ORAL DOSAGE FORM WITH CATIONICALLY CHARGEABLE HYDROGEL FOR DELIVERY OF ACTIVE AGENT | ENTREGA INC. (US) | 2025-05-08 | — | — | WO | claimed |
| EP-2224288-B1 | PHOTOCONDUCTORS COMPRISING EPOXY CARBOXYL RESIN MIXTURE HOLE BLOCKING LAYER | XEROX CORP (US) | 2013-10-16 | — | — | EP | claimed |
| EP-1173878-B1 | PROBES FOR A GAS PHASE ION SPECTROMETER | BIO RAD LABORATORIES (US) | 2011-04-06 | — | — | EP | claimed |
| US-20080000601-A1 | Method for the Production of Paper, Paperboard and Cardboard | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-03 | — | — | US | claimed |
| EP-1792010-A1 | METHOD FOR THE PRODUCTION OF PAPER, PAPERBOARD AND CARDBOARD | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-06 | — | — | EP | claimed |
| EP-1530600-B1 | BIO-SYNTHETIC MATRIX AND USES THEREOF | OTTAWA HEALTH RESEARCH INST (CA) | 2007-03-14 | — | — | EP | claimed |
| US-RE39450-E1 | Polyvinylpyrridinium derivatives as anti-dye transfer agents | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CO (US) | 2006-12-26 | — | — | US | claimed |
| US-20060134050-A1 | Bio-synthetic matrix and uses thereof | FORSKARPATENT I LINKOPING AB (SE) | 2006-06-22 | — | — | US | claimed |
| WO-2006027242-A1 | METHOD FOR THE PRODUCTION OF PAPER, PAPERBOARD AND CARDBOARD | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | WO | claimed |
| US-20060034807-A1 | Innervated artificial tissues and uses thereof | OTTAWA HEALTH RESEARCH INSTITUTE | 2006-02-16 | — | — | US | claimed |
| EP-0296926-B1 | COMPOSITE POLYMERS, THEIR PREPARATION AND THEIR USE IN LIQUID CHROMATOGRAPHY | I.B.F. (FR) | 1992-10-14 | — | — | EP | claimed |
| US-5075371-A | COMPOSITE POLYMERS AND THEIR PREPARATION WHICH ARE USEFUL IN LIQUID CHROMATOGRAPHY | I.B.F. (FR) | 1991-12-24 | — | — | US | claimed |
| US-5053135-A | COMPOSITE POLYMERS, THEIR PREPARATION AND THEIR USE IN LIQUID CHROMATOGRAPHY | I.B.F. (FR) | 1991-10-01 | — | — | US | claimed |
| US-5021167-A | Oil in water emulsion | NALCO CHEMICAL COMPANY (US) | 1991-06-04 | — | — | US | claimed |
| US-4931191-A | Method for separating solids from water using amine containing polymers | NALCO CHEMICAL COMPANY (US) | 1990-06-05 | — | — | US | claimed |
| EP-0331528-A1 | Antimicrobial ethylene copolymers and compositions thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-09-06 | — | — | EP | claimed |
| EP-0296926-A1 | Composite polymers, their preparation and their use in liquid chromatography | I.B.F. (FR) | 1988-12-28 | — | — | EP | claimed |
| EP-0249857-A2 | Photosensitive registration element | BASF Aktiengesellschaft (DE) | 1987-12-23 | — | — | EP | claimed |
| US-4699951-A | MIXTURE OF VINYL HOMOPOLYMER AND, ACRYLAMIDE COPOLYMERIZED WITH VINYL POLYMER | NALCO CHEMICAL COMPANY (US) | 1987-10-13 | — | — | US | claimed |
| US-4238330-A | CATIONIC ACRYLAMIDE COPOLYMER | NALCO CHEMICAL COMPANY (US) | 1980-12-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060034807-A1 | Innervated artificial tissues and uses thereof | NGF, GAP43, NTRK2 | CHRM2 594/4885CHRM4 532/4885CHRM5 445/4885 |
| US-20060134050-A1 | Bio-synthetic matrix and uses thereof | MMP1, HDGF, COL2A1 | CHRM2 4196/4885CHRM4 4269/4885CHRM5 4624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.